Nuclear Radiology: Page 8

Global radiation issues generate discussion in Vienna

By Will Morton

Improving radiation medicine capabilities in poorer countries is essential to bridge the substantial worldwide differences in cancer care, delegates agreed at this week's International Atomic Energy Agency's 2022 Scientific Forum in Vienna.

September 29, 2022

GE, Lantheus highlight flurpiridaz trial results

By AuntMinnieEurope.com staff writers

A phase III trial found that Lantheus Medical Imaging's flurpiridaz F-18 investigational PET radiopharmaceutical outperformed SPECT myocardial perfusion imaging in patients with suspected coronary artery disease.

September 13, 2022

How widespread is fraud in nuclear medicine research?

By Will Morton

Leading Dutch researchers claim that fraud may be a problem in nuclear medicine journals, based on the results of their global survey. Their findings were published on 8 September in the Journal of Nuclear Medicine.

September 12, 2022

First patient in Oncoinvent trial treated for colorectal cancer

By AuntMinnieEurope.com staff writers

Norwegian radiopharmaceutical developer Oncoinvent is highlighting that the first colorectal cancer patient has been treated in a clinical trial of the company's Radspherin drug candidate.

August 25, 2022

U.K. clears Lu-177 PSMA-617 treatment for prostate cancer

By AuntMinnieEurope.com staff writers

The U.K. regulators have become the first in Europe to clear lutetium-177 (Lu-177) prostate-specific membrane antigen (PSMA)-617 treatment for prostate cancer, drug developer Novartis has announced in a news release issued on 11 August.

August 14, 2022

Russia invests in nuclear medicine research facility in Bolivia

By Will Morton

Bolivia has opened a nuclear research center in La Paz -- more than 4000 m above sea level. The $300 million facility is the world's highest-altitude site producing medical radioisotopes, and is a joint effort between the Bolivian Nuclear Energy Agency and the Russian giant Rosatom.

August 14, 2022

ITM selects Marx as chief business officer

By AuntMinnieEurope.com staff writers

German radiopharmaceutical developer ITM Isotope Technologies Munich has named Sebastian Marx, PhD, as its chief business officer.

July 21, 2022

NorthStar inks Ac-225 supply deal with Clovis

By AuntMinnieEurope.com staff writers

NorthStar Medical Radioisotopes has signed a long-term supply agreement with Clovis Oncology for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope.

July 21, 2022

Clarity completes recruitment for prostate cancer trial

By AuntMinnieEurope.com staff writers

Australian radiopharmaceutical developer Clarity Pharmaceuticals has completed recruitment for a PET study of its theranostic agent with copper-based radioisotopes for treating patients with prostate cancer.

July 19, 2022

IAEA, GE to train radiologists in Africa, Latin America

By AuntMinnieEurope.com staff writers

The International Atomic Energy Agency (IAEA) and GE Healthcare will provide medical imaging training to radiologists and nuclear medicine professionals in Africa and Latin America.

July 19, 2022

FDA to allow Bayer to import contrast media

By AuntMinnieEurope.com staff writers

The U.S. Food and Drug Administration (FDA) will now allow Bayer to import a limited quantity of iopromide, initially intended for international markets, for U.S. customers.

July 17, 2022

Jamaica gets first public nuclear medicine center

By AuntMinnieEurope.com staff writers

Jamaica has opened the country's first public nuclear medicine center, at the University Hospital of the West Indies in Kingston, with a ceremony on 30 June noting the support of the International Atomic Energy Agency.

July 10, 2022

Previous Page

Page 8 of 90

Next Page